Cargando…

SARC-F Is a Predictor of Longer LOS and Hospital Readmission in Hospitalized Patients after a Cardiovascular Event

It is already established that sarcopenia is associated with adverse outcomes; however, few studies have focused on patients who have suffered an acute cardiovascular event. The use of SARC-F, a 5-item sarcopenia screening questionnaire, in these patients remains to be investigated. We aimed to inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Fayh, Ana Paula Trussardi, Guedes, Francisco Felipe de Oliveira, Calado, Guilherme Carlos Filgueira, Queiroz, Sandra Azevedo, Anselmo, Marina Gabriely Gomes Barbosa, de Sousa, Iasmin Matias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370486/
https://www.ncbi.nlm.nih.gov/pubmed/35956328
http://dx.doi.org/10.3390/nu14153154
_version_ 1784766814471847936
author Fayh, Ana Paula Trussardi
Guedes, Francisco Felipe de Oliveira
Calado, Guilherme Carlos Filgueira
Queiroz, Sandra Azevedo
Anselmo, Marina Gabriely Gomes Barbosa
de Sousa, Iasmin Matias
author_facet Fayh, Ana Paula Trussardi
Guedes, Francisco Felipe de Oliveira
Calado, Guilherme Carlos Filgueira
Queiroz, Sandra Azevedo
Anselmo, Marina Gabriely Gomes Barbosa
de Sousa, Iasmin Matias
author_sort Fayh, Ana Paula Trussardi
collection PubMed
description It is already established that sarcopenia is associated with adverse outcomes; however, few studies have focused on patients who have suffered an acute cardiovascular event. The use of SARC-F, a 5-item sarcopenia screening questionnaire, in these patients remains to be investigated. We aimed to investigate whether SARC-F can predict adverse outcomes in patients admitted to a hospital with a suspected infarction. This is a 1-year prospective cohort study. During hospitalization, patients completed the SARC-F questionnaire (scores ≥ 4 considered positive for the risk of sarcopenia). Length of hospital stay (LOS), new hospital admission, myocardial infarction, and cardiovascular mortality were collected via medical records and phone interviews. In total, 180 patients were evaluated. The median age was 60.6 years; 72.3% of the participants were men, and half of the sample had comorbidities. The median SARC-F score was 1.0 (interquartile range, 0–3.0), and 21.1% of the participants screened positive. Risk of sarcopenia was independently associated with longer LOS (odds ratio, 2.34; 95% CI, 1.09–5.04; p = 0.030) and hospital readmission (odds ratio, 3.73; 95% CI, 1.60–8.69; p = 0.002). One-fifth of post-acute cardiovascular event patients in this cohort screened positive for sarcopenia using the SARC-F screening questionnaire. Positive scores were associated with a longer LOS and hospital readmission.
format Online
Article
Text
id pubmed-9370486
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93704862022-08-12 SARC-F Is a Predictor of Longer LOS and Hospital Readmission in Hospitalized Patients after a Cardiovascular Event Fayh, Ana Paula Trussardi Guedes, Francisco Felipe de Oliveira Calado, Guilherme Carlos Filgueira Queiroz, Sandra Azevedo Anselmo, Marina Gabriely Gomes Barbosa de Sousa, Iasmin Matias Nutrients Article It is already established that sarcopenia is associated with adverse outcomes; however, few studies have focused on patients who have suffered an acute cardiovascular event. The use of SARC-F, a 5-item sarcopenia screening questionnaire, in these patients remains to be investigated. We aimed to investigate whether SARC-F can predict adverse outcomes in patients admitted to a hospital with a suspected infarction. This is a 1-year prospective cohort study. During hospitalization, patients completed the SARC-F questionnaire (scores ≥ 4 considered positive for the risk of sarcopenia). Length of hospital stay (LOS), new hospital admission, myocardial infarction, and cardiovascular mortality were collected via medical records and phone interviews. In total, 180 patients were evaluated. The median age was 60.6 years; 72.3% of the participants were men, and half of the sample had comorbidities. The median SARC-F score was 1.0 (interquartile range, 0–3.0), and 21.1% of the participants screened positive. Risk of sarcopenia was independently associated with longer LOS (odds ratio, 2.34; 95% CI, 1.09–5.04; p = 0.030) and hospital readmission (odds ratio, 3.73; 95% CI, 1.60–8.69; p = 0.002). One-fifth of post-acute cardiovascular event patients in this cohort screened positive for sarcopenia using the SARC-F screening questionnaire. Positive scores were associated with a longer LOS and hospital readmission. MDPI 2022-07-30 /pmc/articles/PMC9370486/ /pubmed/35956328 http://dx.doi.org/10.3390/nu14153154 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fayh, Ana Paula Trussardi
Guedes, Francisco Felipe de Oliveira
Calado, Guilherme Carlos Filgueira
Queiroz, Sandra Azevedo
Anselmo, Marina Gabriely Gomes Barbosa
de Sousa, Iasmin Matias
SARC-F Is a Predictor of Longer LOS and Hospital Readmission in Hospitalized Patients after a Cardiovascular Event
title SARC-F Is a Predictor of Longer LOS and Hospital Readmission in Hospitalized Patients after a Cardiovascular Event
title_full SARC-F Is a Predictor of Longer LOS and Hospital Readmission in Hospitalized Patients after a Cardiovascular Event
title_fullStr SARC-F Is a Predictor of Longer LOS and Hospital Readmission in Hospitalized Patients after a Cardiovascular Event
title_full_unstemmed SARC-F Is a Predictor of Longer LOS and Hospital Readmission in Hospitalized Patients after a Cardiovascular Event
title_short SARC-F Is a Predictor of Longer LOS and Hospital Readmission in Hospitalized Patients after a Cardiovascular Event
title_sort sarc-f is a predictor of longer los and hospital readmission in hospitalized patients after a cardiovascular event
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370486/
https://www.ncbi.nlm.nih.gov/pubmed/35956328
http://dx.doi.org/10.3390/nu14153154
work_keys_str_mv AT fayhanapaulatrussardi sarcfisapredictoroflongerlosandhospitalreadmissioninhospitalizedpatientsafteracardiovascularevent
AT guedesfranciscofelipedeoliveira sarcfisapredictoroflongerlosandhospitalreadmissioninhospitalizedpatientsafteracardiovascularevent
AT caladoguilhermecarlosfilgueira sarcfisapredictoroflongerlosandhospitalreadmissioninhospitalizedpatientsafteracardiovascularevent
AT queirozsandraazevedo sarcfisapredictoroflongerlosandhospitalreadmissioninhospitalizedpatientsafteracardiovascularevent
AT anselmomarinagabrielygomesbarbosa sarcfisapredictoroflongerlosandhospitalreadmissioninhospitalizedpatientsafteracardiovascularevent
AT desousaiasminmatias sarcfisapredictoroflongerlosandhospitalreadmissioninhospitalizedpatientsafteracardiovascularevent